Close

Analyst Ratings for Takeda Pharmaceutical (TAK)

TAK Rating Summary

TAK Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TAK
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $17.60 (+31.6%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/16/2023 BofA Securities
» Updated 6/13/2023
Koichi Mamegano Upgrade Buy
(Neutral)
18.60
(20.00)
16.08
(13.37)
-16.85% Details
7/19/2022 TD Cowen
» Updated 5/16/2023
Ken Cacciatore Upgrade Buy
(Hold)
20.00
(30.00)
14.41
(13.37)
-7.22% Details
Like TAK Ratings? Also take a look at HCM, ARWR, IMGN, PTGX

TAK Ratings News